Antiestrogen interaction with estrogen receptors and additional antiestrogen binding sites in human breast cancer MCF-7 cells

Archives of Pharmacal Research

Volumn 20, Issue 6, 1997, Pages 579-585

  Ahn, Mee Ryung ^a   Sheen, Yhun Yhong ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Antiestrogen binding sites; Estrogen receptor; MCF 7; MDA MB 231; T47D; trans Tamoxifen

Indexed keywords

EID: 20544464663     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975215     Document Type: Article

References (22)

1. Adelman, M. R., Blobel, G., and Sabatini, D. D. Non-destructive separation of rat liver rough microsomes into ribosomal and membranous components. Methods Enzymol., 31, 201-215 (1974)
2. Bonadonna, G. What did we learn from the results of the international overview about the effects of endocrine therapy? Recent Results Cancer Res., 127, 159-161 (1993).
3. Davidson, N. E., Bronzert, D. A., Chambon, P., Gelmann, E. P., Lippman, M. E. Use of two MCF-7 cell variants to evaluate the growth regulatory potential of trans-tamoxifen-induced products. Cancer Res., 46, 1904-1909 (1986).
4. Dickson, R. B., Thompson, E. W., and Lippman, M. E. Regulation of proliferation, invasion, and growth factor synthesis in breast cancer by steroids. J. Steroid Biochem. Mol. Biol., 37, 305-316 (1990).
5. Eckert, R. L. and Katzellenbogen, B. S. Effects of transtamoxifens and antitrans-tamoxifens on trans-tamoxifen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res., 42, 139-144 (1982).
6. Faye, J. C., Jozan, S., Redeuilth, G., Baulieu, E. E. and Bayard, F. Physicochemical and genetic evidence for specific antiestrogen binding sites. Proc. Natl. Acad. Sci. USA, 80, 3158-3162 (1983).
7. Henderson, I. C. Adjuvant systemictherapy; overview. Recent Results Cancer Res., 127, 197-200 (1993).
8. Horwitz, K. B., and McGuire, W. L. Nuclear mechanism of estrogen receptor action. J. Biol. Chem., 253, 8185-8191 (1978).
9. Katzellenbogen, B. S., Miller, M. A., Mullick, A. and Sheen, Y. Y. Antitrans-tamoxifen action in breast cancer cells. Breast Cancer Res. and Treatment, 5, 231-243 (1985).
10. Katzellenbogen, B. S., Norman, M. J., Eckert, R. L., Peltz, S. W., and Mangel, W. F. Bioactivity eestrogen receptor interactions and plasmin activator inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 breast cancer cells. Cancer Res., 44, 112-119 (1984).
11. King, W. J. and Green G. L. Monoclonal antibodies localize trans-tamoxifen receptor in nuclei of target cells. Nature, 307, 745-747 (1984).
12. Knabbe, C. Regulation of growth inhibitory polypeptides in human breast cancer. In Voigt, K. D. and Knabbe, C. (Eds.). Endocrine-dependent Tumors. Raven Press, New York, pp 165-178, 1991.
13. Lee, H. O., and Sheen, Y. Y. Estrogen modulation of breast cancer cell growth. Arch. Pharm. Res., 20, in press (1997).
14. McGuire, W. L. Steroid receptor sites in cancer therapy. Adv. Intern. Med., 24, 127-140 (1979).
15. Miller, M. A., Lippman, M. E., and Katnellenbogen, B. S. antiestrogen binding in antiestrogen growth resistant estrogen responsive clonal variants of MCF-7 huamn breast cancer cell. Cancer Res., 44, 5038-5045 (1984).
16. Nandi, S. and McGrath, C. M. Mammary neoplasia in mice. Adv. Cancer Res., 17, 354-414 (1973).
17. Ruenitz, P. C., Bagley, J. R., and Pope, C. W. Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen. Drug Metab. and Disposition, 12, 478-483 (1984).
18. Schatchard, G. The attractions of protein for small molecule and ions. Ann. NY Acad. Sci., 51, 660-672 (1949).
19. Sheen, Y. Y., David, M. S. and Katzellenbogen, B. S. An evaluation of the role of antiestrogen binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for estrogen receptor. Endocrinology, 117, 561-564 (1985).
20. Sudo, K., Mondma, F. J., and Katzellenbogen, B. S. Antiestrogen binding sites are distinct from estrogen receptor. Endocrinology, 112, 425-434 (1983).
21. Sutherland, R. L., Foo, M. S., Green, M. D., Waybourne, A. M., and Krozowski, Z.S. High affinity antiestrogen binding sites distinct from the estrogen receptor. Nature, 288, 273-275 (1980).
22. Watts, C. K. W. and Sutherland, R. L. High aaffinity specific antiestrogen binding sites are concentrated in rough endoplasmic microsomal membranes of rat liver. Biochem. Biophys. Res. Commun., 120, 109-115 (1984).